SCHEMBL17897276

SCHEMBL17897276

CC(C)N1CCN(CCCO)CC12CC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17897278 0.81 HTR1A (0.31) —
SCHEMBL15859013 0.79 — —
SCHEMBL24035086 0.77 TSHR (0.33) —
SCHEMBL18948513 0.77 HSD11B1 (0.33) —
SCHEMBL18948456 0.75 — —
SCHEMBL24091632 0.70 TSHR (0.32) —
SCHEMBL25090320 0.70 TSHR (0.32) —
SCHEMBL17897200 0.70 — —
SCHEMBL22309126 0.69 — —
SCHEMBL1404079 0.69 MAOB (0.46) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9676780-B2 Piperazine-substituted [1,2,4]triazolo[1,5-C]quinazolin-5-amine compounds with A2A antagonist properties MERCK SHARP & DOHME CORP. (US) 2017-06-13 — — US disclosed
US-20160194330-A1 PIPERAZINE-SUBSTITUTED [1,2,4]TRIAZOLO[1,5-C]QUINAZOLIN-5-AMINE COMPOUNDS WITH A2A ANTAGONIST PROPERTIES MERCK SHARP & DOHME CORP. (US) 2016-07-07 — — US disclosed
Send feedback